<DOC>
	<DOCNO>NCT02394366</DOCNO>
	<brief_summary>Delayed wound heal lead increase risk infection , thus increase risk morbidity mortality . Skin oxygen delivery peripheral blood flow predict wound heal . The investigator conduct double-masked , placebo-controlled cross-over clinical pilot trial order evaluate effect topical , homeopathic/herbal salve ( Original Healing Salve , Puremedy , Inc. ) skin oxygenation peripheral blood flow .</brief_summary>
	<brief_title>Topical Salve Skin Oxygenation Blood Flow</brief_title>
	<detailed_description>Delayed wound heal lead increase risk infection , thus increase risk morbidity mortality . Skin oxygen delivery peripheral blood flow predict wound heal . In order evaluate effect topical , homeopathic/herbal salve ( Original Healing Salve , Puremedy , Inc. ) skin oxygenation peripheral blood flow , investigator conduct double-masked , placebo-controlled cross-over clinical pilot trial randomize test order evaluate effect salve cutaneous oxygen saturation ( TcPO2 ) ankle-to-brachial pressure index ( ABPI ) . The investigator recruit thirty-two participant two cohort participate , one one without type 2 diabetes , otherwise generally healthy without active wound , ulcer skin rash . Both TcPO2 ABPI measure application homeopathic/herbal salve ( `` active '' ) , application inert salve base ( `` placebo '' ) . Analyses compare pre/post change TcPO2 ABPI application active salve within visit , also compare change active salve change TcPO2 ABPI measure placebo salve . If Original Healing Salve improve cutaneous oxygenation and/or ABPI , future research may evaluate formula specifically wind heal antimicrobial effect . Thus propose research pilot study target mechanistic outcome , predict potential clinical efficacy . The propose research significant , low cost , effective treatment need improve wound heal reduce morbidity associate complication delay wound healing .</detailed_description>
	<criteria>Have type 2 diabetes without known complication , i.e. , eye damage ( retinopathy ) , nerve damage ( diabetic peripheral neuropathy ) , kidney damage ( diabetic kidney disease ) , heart damage ( recent myocardial infarction severe congestive heart failure ) Age ≥ 18 ≤ 75 Willing able give inform consent Able follow protocol attend visit Able read write English Active malignancy , exclude basal cell carcinoma , squamous cell carcinoma , and/or carcinoma situ cervix . If present , dermal cancer may locate around test site . A recent cardiovascular event ( e.g. , myocardial infarction , stroke ≤ six month prior screen visit ) , current coronary artery disease , angina , stage III IV congestive heart failure , state history coronary bypass surgery heart stent placement . Current active diabetic ulcer . History diabetic neuropathy . Diagnosis type 2 diabetes longer 10 year . Diagnosis type 1 diabetes . Established diagnosis peripheral artery disease ( PAD ) intermittent claudication . Established diagnosis peripheral venous disease ( PVD ) chronic venous insufficiency . Active rash , wound , ulcer low leg , include psoriasis eczema . Presence edema &gt; +1 ; pit non pit . Currently take follow betablocker medication ( due potential impact peripheral vasodilation ) : acebutolol ( Sectral® ) , atenolol ( Tenormin® ) , betaxolol ( Kerlone® ) , bisoprolol fumarate ( Zebeta® , Ziac® ) , carvedilol ( Coreg® ) , metoprolol ( Lopressor® , Toprol XL® ) , nadolol ( Corgard® ) , nebivolol ( Bystolic® ) , penbutolol ( Levatol® ) , propranolol ( Hemangeol® , Inderal LA® Inderal XL® , InnoPran XL® ) , esmolol ( Brevibloc ) , sotalol ( Betapace , Sorine ) , labetalol ( Normodyne , Trandate ) , pindolol ( Visken ) . Currently take follow cholinergic medication ( due potential impact peripheral vasodilation ) : acetylcholine , atropine , bethanechol ( Urecholine® ) , donepezil ( Aricept® ) , ipratropium bromide ( Atrovent® ) , neostigmine ( Prostigmine® ) , nicotine ( Nicoderm® , Nicotrol® ) , oxybutynin ( Ditropan® ) , physostigmine , pilocarpine ( Salagen® ) , pralidoxime ( Protopam® ) , succinylcholine ( Anectine® ) , tiotropium bromide ( Spiriva® , Tiova® ) , tolterodine ( Detrol® ) , vecuronium ( Norcuron® ) . Allergy ingredient find study product : pine resin , balsam fir resin , elder ( Sambucus ) flower bark , marigold ( Calendula ) , cone flower ( Echinacea ) , olive oil , safflower oil beeswax . Walking Impairment Questionnaire Speed Scores 018 due risk PAD ( 21 ) . Walking Impairment Questionnaire Distance Scores 019 due risk PAD ( 21 ) . Presence unstable and/or significant medical disorder would compromise participant 's safety take part trial . Use tobacco product , ecigarettes , nicotine patch and/or nicotine gum Scleroderma Raynaud 's Planned elective surgery within next 6 week Pregnant , nursing , plan pregnancy within next 6 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Skin oxygenation</keyword>
	<keyword>peripheral perfusion</keyword>
</DOC>